xcur stock buy or sell

It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. See rankings and related performance below. Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Get Wall Street analysts ratings for Exicure, Inc. (XCUR). During the day the stock fluctuated 7.20% from a day low at $4.04 to a day high of $4.33. Get the latest Exicure, Inc. XCUR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. What's Happening With Exicure Inc Stock Today? Click here to watch the full series. Technical Analysis for XCUR - Exicure, Inc. Buy or Sell? During the last day, the stock moved $0.24 between high and low, or 9.27%. Find the latest analyst research for Exicure, Inc. Common Stock (XCUR) at Nasdaq.com. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Zacks Rank Education -- Learn more about the Zacks Rank Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. also free. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. See all Medical - Biomedical and Genetics Peers. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. A "buy" rating indicates that analysts believe XCUR will outperform the market and that investors should add to their positions of … The company traded as low as $2.35 and last traded at $2.36. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Exicure, Inc. has been showing a declining tendency so we believe that similar market … Zacks Rank Education -- Learn more about the Zacks Rank A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Exicure Inc. Invest in Exicure Inc stock … The stock had previously closed at $2.54. The consensus among Wall Street analysts is that investors should "buy" Exicure stock. publicly available sources. Zacks Ranks stocks can, and often do, change throughout the month. If the total is less than zero, then this is a "Sell". Their average twelve-month price target is $9.60, predicting that the stock has a possible upside of 291.84%. XCUR: Get the latest Exicure stock price and detailed information including XCUR news, historical charts and realtime prices. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Stock screener for investors and traders, financial visualizations. XCUR closed down 0.48 percent on Friday, March 5, 2021, on 1.53 times normal volume. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. The Zacks Rank has been called the Billion Dollar Secret. However, rules govern insider transactions, and certain disclosures are required. Exicure Inc (XCUR) stock is trading at $1.93 as of 2:35 PM on Thursday, Oct 8, an increase of $0.27, or 16.67% from the previous closing price of $1.65. Out of 2 analysts, 1 ( 50% ) are recommending XCUR as a Strong Buy, 1 ( 50% ) are recommending XCUR as a Buy, 0 ( 0% ) are recommending XCUR as a Hold, 0 ( 0% ) are recommending XCUR as a Sell, and 0 ( 0% ) are recommending XCUR … Analyst Report: Bristol-Myers Squibb Company, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. XCUR Technical Analysis. How good is it? See the Full List of Stocks To Beat Earnings. 2.4400 -0.01 (-0.41%)After hours: 7:49PM EDT, Subscribe to Premium to view Fair Value for XCUR. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Exicure, Inc. (XCUR), ... Yield and return will vary, therefore, you may have a gain or loss when you sell your shares. Zacks Style Scores Education - Learn more about the Zacks Style Scores. the Web site, including, but not limited to Information originated by Zacks The high price target for XCUR is $18.00 and the low price target for XCUR is $6.00. XCUR is down -$0.21 from the previous closing price of $2.80 on volume of 675,507 shares. Use the Zacks Rank and Style Scores to find out is XCUR is right for your portfolio. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking. If you wish to go to ZacksTrade, click OK. Sign-up to receive the latest news and ratings for XCUR and its competitors with Analyst Ratings Network’s free daily newsletter. The stock has a consensus analyst rating of "Buy." See what the analysts say. These returns cover a period from January 1, 1988 through March 1, 2021. XCUR has been the subject of several analyst reports. This is an estimated date of earnings release. Post-Market 0.00 (0.00%) Exicure Inc NASDAQ Updated Mar 16, 2021 11:56 PM. Plus, XCUR info will be updated daily in your Zacks.com Portfolio Tracker . The consensus among 2 Wall Street analysts covering ( NASDAQ : XCUR ) stock is to Strong Buy XCUR stock. ... Do not sell my personal information. XCUR 2.59 0.07 (2.78%). You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Quotes delayed 15 … Exicure, Inc. (NASDAQ:XCUR) fell 7.1% on Thursday . What Is Insider Selling? To learn more, click here. ZacksTrade and Zacks.com are separate companies. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how XCUR will perform in the near future. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. Delayed quotes by Sungard. Bullish Indicators Bearish Indicators Fortress Biotech stock price ended on $4.18 on Tuesday after losing 2.34% (Updated on March 16, 2021) Buy or Hold candidate since 2021-02-01 Gain 26.28% PDF The Fortress Biotech stock price fell by -2.34% on the last day (Tuesday, 16th Mar 2021) from $4.28 to $4.18. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Buy Exicure Inc stock (XCUR). If you are thinking about buying XCUR, make sure you check out the free XCUR stock predictions report provided by MarketClub. Business Wire. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy." There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Simply Wall St has no position in the stocks mentioned. If you do not, click Cancel. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. completeness, timeliness, or correct sequencing of any of the Information on 681,064 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 653,880 shares. . So before you buy or sell Exicure, Inc. (NASDAQ:XCUR), you may well want to know whether insiders have been buying or selling. ... Is XCUR A Good Stock To Buy Now? See Exicure Inc real time stock price, historical quotes and price charts. The monthly returns are then compounded to arrive at the annual return. ... and a bulleted list of reasons to buy or sell the stock. Learn about XCUR (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. The technique has proven to be very useful for finding positive surprises. Should I buy Exicure, Inc. (XCUR)? All rights reserved. For the last week, the stock has had a daily average volatility of 10.96%. |  Privacy Policy. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Exicure Inc. is based in IL, United States. Neither Zacks Investment See Zacks' prediction free. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. * indicates the important links in the menu. If you are looking for stocks with good return, Exicure Inc stock can be a bad, high-risk 1-year investment option. ... and a bulleted list of reasons to buy or sell the stock. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exicure in the last year. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. The cost of a stock on each day is given in an array, find the max profit that you can make by buying and selling in those days. XCUR is trading in the range of $1.93 - $2.83 in the past 30 days. Exicure Inc (XCUR) stock has fallen -7.5% while the S&P 500 has gained 0.66% as of 2:45 PM on Wednesday, Jan 8. XCUR Stock Predictions. This article by Simply Wall St is general in nature. The analysis is useful for short term traders who trade stocks with technical anlaysis. We use cookies to understand how you use our site and to improve your experience. If the total is zero, then this is a "Hold". There is a sell signal from a pivot top found 3 day(s) ago.) Since 1988 it has more than doubled the S&P 500 with an average gain of +25.41% per year. Visit www.zacksdata.com to get our data and content for your mobile app or website. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Information Providers, or gathered by Zacks Investment Research, Inc. from The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. XCUR lost -$0.43 per share the over the last 12 months. Stay up to date with Exicure Inc stock news. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Visit Performance Disclosure for information about the performance numbers displayed above. in the Information. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Exicure reported fourth quarter and full year financial results for the year ended December 31, 2020 and provided an update on corporate progress. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Exicure Inc (NASDAQ:XCUR) Real-Time Quotes. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Exicure Inc. is a clinical-stage biotechnology company. To keep the results in a more logical format, we factor the overall opinion by 1.04 to keep the end result in multiples of 8 percentage points, with the exception of a … Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Wayfair is benefiting from a growing millennial population, which will lead to rising housing sales. Our recommended stop-loss: $2.57 (-4.60%) (This stock has high daily movements and this gives high risk. Over the past year the S&P 500 is up 26.58% while XCUR is down -15.36%. As the shares of Textron and other defense contractors recover to pre-Covid levels, the shares of Axon Enterprise, manufacturer of the popular … As of 2021 March 09, Tuesday current price of XCUR stock is 2.260$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Nov-16-20 07:00AM : Exicure to Participate in Upcoming Conferences. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. Is Exicure Stock a good buy in 2021, according to Wall Street analysts? The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. This includes personalizing content and advertising. It's packed with all of the company's key stats and salient decision making information. The scores are based on the trading styles of Value, Growth, and Momentum. If the total is greater than zero, then this is a "Buy". Exicure, Inc. (XCUR), ... Yield and return will vary, therefore, you may have a gain or loss when you sell your shares. Should I buy or sell XCUR stock? The following Exicure technical analysis is based on short term price movement and trend analysis. XCUR | Complete Exicure Inc. stock news by MarketWatch. For example, if the given array is {100, 180, 260, 310, 40, 535, 695}, the maximum profit can earned by buying on day 0, selling on day 3. NASDAQ data is at least 15 minutes delayed. Spherical Nucleic Acid technology shows promising results in phase 0 trial in patients with glioblastoma at Northwestern University. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. NYSE and AMEX data is at least 20 minutes delayed. Research, Inc. nor its Information Providers can guarantee the accuracy, View real-time stock prices and stock quotes for a full financial overview. Find real-time XCUR - Exicure Inc stock quotes, ... Do Not Sell. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Buy or Sell this stock? There are currently 5 buy ratings for the stock. . Find out if Wayfair stock is a buy, sell, or hold. XCUR is down -2.00% on 03/12/21. Insider Monkey. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Today. Real time prices by BATS. View analyst ratings for Exicure or view top-rated stocks. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Find the latest Exicure, Inc. (XCUR) stock quote, history, news and other vital information to help you with your stock trading and investing. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. the stock is 61.2% away from all-time highs of $6.5: xcur is up 42% since the beginning of the year: xcur is up 14% over the past 12 months: xcur is up 11% over the past 1 month: 2% of all xcur investors are betting against xcur: num investors short xcur has gone up 10% versus last month Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Exicure Inc real time quote is equal to 2.595 USD at 2021-03-17, but your current investment may be devalued in the future. No cost, no obligation to buy anything ever. There may be delays, omissions, or inaccuracies © 2021 Verizon Media. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Analyst Price Target for XCUR i $ 10.50 ... ARN does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
xcur stock buy or sell 2021